IQVIA Nordics | LinkedIn (original) (raw)
Om oss
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA Nordics has operation in Finland, Denmark, Norway and Denmark with close to 600 employees. IQVIA Nordics helps authorities, interest groups, pharmacies, hospitals, and companies in the pharmaceutical industry and MedTech to gain new insights and in-depth knowledge. To learn more, visit www.iqvia.com.
Bransch
Sjukhus och hälsovård
Företagsstorlek
Fler än 10 001 anställda
Huvudkontor
Solna, Sverige
Typ
Privatägt företag
Specialistområden
Master Data Management, Business Intelligence Applications, Cloud Services, Healthcare IT, Healthcare Consulting, Healthcare data, Business Intelligence, Real World Data, Clinical Research, Market Research, Market Access, Health Economics, CRM, Data Science, Research & Development, Commercial Effectivness och Advanced Analytics
Adresser
- Primär
Arenastaden
Pyramidvägen 7
Solna, Sverige 169 56 , SE
Få vägbeskrivning - Blegdamsvej 104C
København Ø, 2100, DK
Få vägbeskrivning - Tollbugata 8B
Oslo, Norge 0152, NO
Få vägbeskrivning - Metsänneidonkuja 6
DUO Building
Espoo, Sydfinland 02130, FI
Få vägbeskrivning - Humalistonkatu 1
Turku, Southwest Finland 20100, FI
Få vägbeskrivning - Prästgårdsgatan 28
Mölndal, SE
Få vägbeskrivning
Anställda på IQVIA Nordics
Uppdateringar
- Join our upcoming webinar to look ahead of 2025. This webianar provides a review of nine issues which are new or see inflection points in 2025, transforming global life sciences, healthcare systems or the pharmaceutical industry in 2025 and beyond.
Life sciences and the pharmaceutical industry is evolving rapidly. Our upcoming webinar, "Nine for 2025," will cover critical topics like the advancement of AI in healthcare, what therapeutic breakthroughs we can expect in the next year, and the future of the obesity market to name a few. Stay ahead of the curve and register nowhttps://bit.ly/3UPFQLk -
8 904 följare
2 d Redigerad
Today, our Nordic team gathered for an insightful seminar, where we delved into the future of healthcare and digital collaboration. The agenda was packed with engaging presentations and discussions, providing valuable insights into the evolving landscape of the industry. One of the highlights was the presentation of the Valo project 'Value from Nordic Health Data' by IQVIA's Susanna Flaherty. This was followed by an enlightening session on digital collaboration in the future, presented by Lars Hulbaek, Director of MedCom, who shared his perspective on digital collaboration through the lens of MedCom. The day continued with a deep dive potential of AI in shaping the future of healthcare featuring presentations on IQVIA Health-grade AI by Søren Bæk and AI Chatbot large language modules & Governance by Admed Zewain from 2021.AI. The day ended with a top relevant discussion around the future of the Danish healthcare system, exploring various perspectives and positions on the government's new healthcare reform communicated earlier today. The panel debate, facilitated by IQVIA's Jesper Eriksen, featured Kjeld Møller Pedersen, Professor of Health Economics at the University of Southern Denmark, and Jørgen Schøler Kristensen, Chairman of the Medicine Council. -
8 904 följare
6 d Redigerad
At today's MVA Annual Summit 2024 industry leaders, researchers, and experts came together to explore the latest advancements and opportunities in the vibrant Medicon Valley region. The discussions under the theme 'Faster, Higher, Stronger Together' were inspiring and it was great to get an update on the brand new Swedish life science strategy. Jeanette Edblad, Director of the Office for Life Sciences, Regeringskansliet emphasized the endless possibilities of healthcare data, the importance of competitive offerings, efficient regulations, and a focus on increased patient benefits. The government's commitment to significantly increasing clinical trials and the emphasis on preventing diseases before they break out were also key takeaways from an inspiring day kindly hosted by Medicon Valley Alliance . - Optimize investments through the right channel mix! Join our upcoming Nordic webinar "Level up your promotional strategy" where we will analyze the promotional landscape for pharmaceutical companies in the Nordics to understand the impact of promotional channels. https://bit.ly/4fzBK1S
-
8 904 följare
1 v Redigerad
Last week Carita Grahn, Clinical Operations Manager in IQVIA, took part in the Nordic-Baltic Conference in Clinical Trials 2024. The discussion focused on actions to boost clinical trials in the area and how to make Finland more attractive for conducting more clinical trials. Different countries introduced their national strategies and best practices. Finland is renowned for its strong performance in clinical trials, thanks to its skilled healthcare professionals, motivated patients, and comprehensive patient registers. However, the number of new clinical trials has decreased recently, highlighting the need for improvements in legislation, permit processes, and funding. At IQVIA we are happy to be part of this important discussion contributing with industry knowledge and potential solutions. - Do you want to increase your market share and engage with HCPs in an efficient way? Let us inspire you in our upcoming webinar discussing how pharma companies can take advantage of omnichannel marketing while being compliant. Let us inspire you to perform data driven marketing adhering to GDPR, cookie rules, local legislation and other legal matters. We even provide a lawyer whom you can ask questions - free of charge. Sign up now: https://bit.ly/3CjAPV6
-
8 904 följare
1 v Redigerad
We had a fantastic time hosting a panel discussion at #BioEurope yesterday! A big thank you to our panel of CEOs Anta Gkelou, Jennifer Schneider, Aneta Sottil moderated by Emma Chaffin for sharing their insights on navigating biotech's clinical development challenges and their strategies for thriving in 2024’s complex landscape. The session was highly attended, and the audience were deeply engaged and appreciative of the valuable knowledge shared. If you were not able to attend, get in touch to discover how we can support you along your biotech journey https://bit.ly/3YF0C1c - Join our upcoming webinar about rapidly growing obesity market on November 18th.
Join IQVIA's Launch Excellence webinar to explore the rapidly growing obesity market with insights from IQVIA experts. Discover competitive trends, stakeholder perspectives, and strategic positioning. Register now: https://bit.ly/4e0J05O - Clinical trial initiations in the biotech industry have reduced by 60% in 2024 and funding is still low compared to previous years. Emma Chaffin is hosting a session at #BioEurope to gain evidence-based insights from biotech leaders Anta Gkelou, Jennifer Schneider and Aneta Sottil. At BIO-Europe? Join the session and book a meeting to explore how to address the challenges in biotech's clinical developmenthttps://bit.ly/4hJ8F6a
- How to communicate effectively with HCPs in an omnichannel environment while maintaining compliance. Get an update and answers to your legal questions on our upcoming webinar. Sign up here:https://bit.ly/3Aqih4S